Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -230.92% is 36% above its 5-year average of -361.04%, near the high end of its 5-year range (-2621.66%–423.47%).
18.31% above its 12-month average of -282.68%.
Reported quarterly operating margin; no daily interpolation. Q1 FY2026 (2026-03-31): -263.47%.
OPERATING MARGIN
-230.92%
OPERATING MARGIN AVG TTM
-282.68%
OPERATING MARGIN AVG 3Y
-161.29%
OPERATING MARGIN AVG 5Y
-361.04%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+18.31%
CURRENT VS 3Y AVG
-43.17%
CURRENT VS 5Y AVG
+36.04%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Celularity Inc.
Market Cap
$49.50M
Operating Margin
-230.92%
TTM Avg
-282.68%
3Y Avg
-161.29%
5Y Avg
-361.04%
Market Cap
$49.96M
Operating Margin
-11541.50%
TTM Avg
-10608.91%
3Y Avg
-9412.76%
5Y Avg
-9062.71%
Market Cap
$50.25M
Operating Margin
-9240.66%
TTM Avg
-8899.44%
3Y Avg
-6820.53%
5Y Avg
-4916.43%
Market Cap
$50.51M
Operating Margin
-111.45%
TTM Avg
-10696.13%
3Y Avg
-10482.04%
5Y Avg
-431164.93%
Market Cap
$51.12M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.58M
Operating Margin
-61738.00%
TTM Avg
-183136.86%
3Y Avg
-98100.06%
5Y Avg
-86611.75%
Market Cap
$46.79M
Operating Margin
-1.45%
TTM Avg
4.45%
3Y Avg
-26.46%
5Y Avg
-35.98%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celularity Inc. (CELU) | $49.50M | -230.92% | -282.68% | -161.29% | -361.04% |
| biote Corp. (BTMD)vs › | $49.40M | 18.50% | 17.27% | 3.29% | 10.87% |
| Clene Inc. (CLNN)vs › | $49.96M | -11541.50% | -10608.91% | -9412.76% | -9062.71% |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | -9240.66% | -8899.44% | -6820.53% | -4916.43% |
| Apollomics, Inc. (APLM)vs › | $50.51M | -111.45% | -10696.13% | -10482.04% | -431164.93% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| INmune Bio, Inc. (INMB)vs › | $51.58M | -61738.00% | -183136.86% | -98100.06% | -86611.75% |
| BioStem Technologies, Inc. (BSEM)vs › | $46.79M | -1.45% | 4.45% | -26.46% | -35.98% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.95M | N/A | -19.41% | -9.70% | -6.47% |
Gross Margin
79.6%
Operating Margin
-230.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | -263.47% |
| 2025-12-31 | -537.48% |
| 2025-09-30 | -244.13% |
| 2025-06-30 | -276.57% |
| 2025-03-31 | -91.77% |
| 2024-12-31 | -51.18% |
| 2024-09-30 | -124.00% |
| 2024-06-30 | -84.01% |
| 2024-03-31 | -50.24% |
| 2023-12-31 | 109.93% |
| 2023-09-30 | -2621.66% |
| 2023-06-30 | -1445.75% |
| 2023-03-31 | -1623.13% |
| 2022-12-31 | 423.47% |
| 2022-09-30 | -136.54% |
| 2022-06-30 | 110.57% |
| 2022-03-31 | -701.16% |
| 2021-12-31 | -307.89% |
| 2021-09-30 | 102.60% |
| 2021-06-30 | -1895.87% |
| 2021-03-31 | -1668.98% |
| 2020-12-31 | 340.89% |
| 2020-09-30 | -143.25% |
| 2020-06-30 | -3950.98% |
| 2020-03-31 | -498.95% |
| 2019-12-31 | -628.32% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
